Molecular Chaperone HSP90 Is Necessary to Prevent Cellular Senescence Via Lysosomal

Total Page:16

File Type:pdf, Size:1020Kb

Molecular Chaperone HSP90 Is Necessary to Prevent Cellular Senescence Via Lysosomal Author Manuscript Published OnlineFirst on October 28, 2016; DOI: 10.1158/0008-5472.CAN-16-0613 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 1 Molecular chaperone HSP90 is necessary to prevent cellular senescence via lysosomal 2 degradation of p14ARF 1,7 1,7 2,3 2,4 1 1 3 Su Yeon Han , Aram Ko , Haruhisa Kitano , Chel Hun Choi , Min-Sik Lee , Jinho Seo , 5 6 2 2 1 4 Junya Fukuoka , Soo-Youl Kim , Stephen M. Hewitt , Joon-Yong Chung , Jaewhan Song 5 Affiliations and addresses 1 6 Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, 7 Seoul, Korea 2 8 Experimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, 9 National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA 3 10 Department of Thoracic Surgery, Shiga University of Medical Science, Otsu 520-2192, 11 Japan 4 12 Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan 13 University School of Medicine, Seoul 135-710, Republic of Korea 5 14 Department of Pathology, Nagasaki University Graduate School of Biomedical Sciences, 15 Nagasaki, 852-8523, Japan 6 16 Cancer Cell and Molecular Biology Branch, Division of Cancer Biology, Research Institute, 17 National Cancer Center, Goyang 410-769, Republic of Korea 7 18 These authors contributed equally to this work. 19 Running title: HSP90-mediated p14ARF degradation in NSCLC 20 Key words: p14ARF, HSP90, NSCLC, Lysosome-dependent degradation, Senescence 21 Funding: This work was supported by grants from the Basic Science Research Program of 22 the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT 23 and Future Planning (2014R1A1A1002589) (S Han, A Ko) and from the National Cancer 1 Downloaded from cancerres.aacrjournals.org on September 27, 2021. © 2016 American Association for Cancer Research. Author Manuscript Published OnlineFirst on October 28, 2016; DOI: 10.1158/0008-5472.CAN-16-0613 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 24 Center, Korea (NCC-1420300) (J Song). 25 Correspondence to: Jaewhan Song, PhD, Department of Biochemistry, Yonsei University, 26 Sinchon-dong, Seadaemun-gu, Seoul 120-749, Korea. Tel.: +82 2 2123 7631; Fax: +82 2 362 27 9897; E-mail: [email protected] 28 29 The authors have declared that no conflict of interest exists. 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 2 Downloaded from cancerres.aacrjournals.org on September 27, 2021. © 2016 American Association for Cancer Research. Author Manuscript Published OnlineFirst on October 28, 2016; DOI: 10.1158/0008-5472.CAN-16-0613 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 47 Abstract 48 The tumor suppressor function of p14ARF is regulated at a post-translational level via 49 mechanisms yet to be fully understood. Here we report the identification of an 50 unconventional p14ARF degradation pathway induced by the chaperone HSP90 in 51 association with the E3 ubiquitin ligase CHIP. The ternary complex of HSP90, CHIP and 52 p14ARF was required to induce the lysosomal degradation of p14ARF by a ubiquitination- 53 independent but LAMP2A-dependent mechanism. Depletion of HSP90 or CHIP induced 54 p14ARF-dependent senescence in human fibroblasts. Premature senescence observed in cells 55 genetically deficient in CHIP was rescued in cells that were doubly deficient in CHIP and 56 p14ARF. Notably, non-small-cell lung cancer cells (NSCLC) positive for p14ARF were 57 sensitive to treatment with the HSP90 inhibitor geldanamycin. Further, overexpression of 58 HSP90 and CHIP with a concomitant loss of p14ARF correlated with poor prognosis in 59 patients with NSCLC. Our findings identify a relationship between p14ARF and its 60 chaperones that suggest new therapeutic strategies in cancers which overexpress HSP90. 61 62 63 64 65 66 67 68 69 3 Downloaded from cancerres.aacrjournals.org on September 27, 2021. © 2016 American Association for Cancer Research. Author Manuscript Published OnlineFirst on October 28, 2016; DOI: 10.1158/0008-5472.CAN-16-0613 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 70 Introduction 71 Non-small-cell lung cancer (NSCLC) constitutes approximately 85-90% of lung cancers, 72 with a 5-year survival rate of 15.9% (1, 2). NSCLC is a primary subtype of lung cancer that 73 displays relative insensitivity to chemotherapy and radiotherapy compared with small-cell 74 lung cancer (SCLC), which accounts for the majority of other lung cancers (3-7). NSCLC 75 displays genetic and cellular heterogeneity such as mutation and amplification of oncogenes 76 including HER2, MET, FGFR1, FGFR2, ALK, ROS1, NRG1, NTRK1 and RET (2, 8-10). In 77 contrast, a small number of inhibitors with specific targets such as EGRF mutation or EML4– 78 ALK fusion are currently available for clinical NSCLC treatment. Other clinical trials using 79 inhibitors that target driver mutations including FGFR, DDR2, KRAS and PI3K are also 80 currently underway (11). 81 HSP90 is a major factor that maintains the stability of a variety of proteins. Thus, 82 perturbation of the status of HSP90 would disturb cellular homeostasis, leading to cancer cell 83 death. HSP90 is involved in various cellular mechanisms such as protein folding and 84 activation, cell cycle control, and transcriptional regulation (12-14). In addition to enabling 85 cancer cells to cope with drastic changes in protein homeostasis, HSP90 displays tumorigenic 86 properties via stabilization of the oncogenic proteins such as HER2, AKT, TERT, Raf1, 87 mutant p53, etc (14-27). Because inhibiting HSP90 leads to destabilization of its client 88 oncoproteins, several HSP90 inhibitors were developed as cancer drugs and underwent 89 clinical trials in various human cancers (28). Treatment with geldanamycin (GA) inhibits 90 HSP90 ATPase activity, which is essential for the degradation of HSP90 client oncoproteins 91 and stimulates cell cycle arrest and apoptosis (29). Recent reports have also suggested that 92 GA treatment induces cellular senescence by an unknown mechanism (30). Although HSP90 4 Downloaded from cancerres.aacrjournals.org on September 27, 2021. © 2016 American Association for Cancer Research. Author Manuscript Published OnlineFirst on October 28, 2016; DOI: 10.1158/0008-5472.CAN-16-0613 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 93 may play a role in cellular senescence through TERT stabilization, the accurate mechanism of 94 HSP90 inhibition-induced cellular senescence remains to be identified (26, 31). C-terminus 95 of HSP70-interacting protein (CHIP) is one of the major co-chaperones of HSP90 and can 96 regulate the ubiquitylation and degradation of HSP90 target proteins. CHIP contains the N- 97 terminal TPR domain and C-terminal U-Box domain, which are required for the interaction 98 with chaperones and for the recruitment of the E2 enzyme and ubiquitylation, respectively 99 (32, 33). In association with HSP70, CHIP typically induces the degradation of HSP90 client 100 proteins when HSP90 fails to induce their structural maturation into their native forms 101 possibly through a hostile environment or HSP90 inhibition by drugs (33). 102 p14ARF is an alternative reading frame product of the INK4a/ARF locus and functions as a 103 tumor suppressor through p53-dependent and p53-independent pathways (34). p14ARF is 104 transcriptionally induced by oncogenic signaling such as c-myc and causes oncogene-induced 105 senescence, which results in tumor suppression (35). While p14ARF has been reported to be 106 regulated by post-translational modifications (10, 11, 36), the roles of molecular chaperones 107 in directly modulating p14ARF levels and the related cellular senescence have not been 108 identified. Here, we demonstrate that HSP90 plays a powerful oncogenic role by inducing 109 p14ARF degradation, which prevents cellular senescence. The ternary complex of HSP90, 110 CHIP and p14ARF was required to induce the ubiquitylation-independent and LAMP2A- 111 dependent lysosomal degradation of p14ARF. Furthermore, HSP90 and CHIP overexpression 112 together with a loss of p14ARF expression correlated with poor prognosis in advanced 113 human NSCLC and served as an important prognostic marker. This study is the first to 114 identify molecular chaperone-mediated degradation of the tumor suppressor p14ARF and to 115 demonstrate its clinical importance in NSCLC. 5 Downloaded from cancerres.aacrjournals.org on September 27, 2021. © 2016 American Association for Cancer Research. Author Manuscript Published OnlineFirst on October 28, 2016; DOI: 10.1158/0008-5472.CAN-16-0613 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 116 Materials and methods 117 Cell culture and transfection 118 An embryonic kidney cell line (293T), a cervical cancer cell line (HeLa), a human NSCLC 119 cell line (H1299), the IMR90 fibroblast line, the HFF line and human lung cancer cell lines 120 including A549, NCI-H460, NCI-H522, NCI-H23 and NCI-H226 were provided by 121 American Type Culture Collection (ATCC, Manassas, VA). The human lung cancer cell lines 122 including NCI-H322M, HOP62 and EKVX were provided from the U.S. National Cancer 123 Institute (NCI; MTA no. 2702-09). PC-9 cells were purchased in 2015 from Sigma-Aldrich 124 Corporation (St. Louis, MO). 293T, HeLa, IMR90 and HFF were obtained in 2014. H1299 125 was purchased in 2012. Rest of cell lines were obtained in 2009. 126 All lung cancer cell lines except PC-9 and H1299 were tested and authenticated annually by 127 STR test in National Cancer Center Core Facility, Korea. STR profile was analyzed using 128 Gene Mapper v 5.0 software. All the provided cell lines were aliquoted and frozen within 129 passage 10, and experiments were performed using thawed cell lines from passage 7 to 18.
Recommended publications
  • Proteasomes: Unfoldase-Assisted Protein Degradation Machines
    Biol. Chem. 2020; 401(1): 183–199 Review Parijat Majumder and Wolfgang Baumeister* Proteasomes: unfoldase-assisted protein degradation machines https://doi.org/10.1515/hsz-2019-0344 housekeeping functions such as cell cycle control, signal Received August 13, 2019; accepted October 2, 2019; previously transduction, transcription, DNA repair and translation published online October 29, 2019 (Alves dos Santos et al., 2001; Goldberg, 2007; Bader and Steller, 2009; Koepp, 2014). Consequently, any disrup- Abstract: Proteasomes are the principal molecular tion of selective protein degradation pathways leads to a machines for the regulated degradation of intracellular broad array of pathological states, including cancer, neu- proteins. These self-compartmentalized macromolecu- rodegeneration, immune-related disorders, cardiomyo- lar assemblies selectively degrade misfolded, mistrans- pathies, liver and gastrointestinal disorders, and ageing lated, damaged or otherwise unwanted proteins, and (Dahlmann, 2007; Motegi et al., 2009; Dantuma and Bott, play a pivotal role in the maintenance of cellular proteo- 2014; Schmidt and Finley, 2014). stasis, in stress response, and numerous other processes In eukaryotes, two major pathways have been identi- of vital importance. Whereas the molecular architecture fied for the selective removal of unwanted proteins – the of the proteasome core particle (CP) is universally con- ubiquitin-proteasome-system (UPS), and the autophagy- served, the unfoldase modules vary in overall structure, lysosome pathway (Ciechanover, 2005; Dikic, 2017). UPS subunit complexity, and regulatory principles. Proteas- constitutes the principal degradation route for intracel- omal unfoldases are AAA+ ATPases (ATPases associated lular proteins, whereas cellular organelles, cell-surface with a variety of cellular activities) that unfold protein proteins, and invading pathogens are mostly degraded substrates, and translocate them into the CP for degra- via autophagy.
    [Show full text]
  • The HSP70 Chaperone Machinery: J Proteins As Drivers of Functional Specificity
    REVIEWS The HSP70 chaperone machinery: J proteins as drivers of functional specificity Harm H. Kampinga* and Elizabeth A. Craig‡ Abstract | Heat shock 70 kDa proteins (HSP70s) are ubiquitous molecular chaperones that function in a myriad of biological processes, modulating polypeptide folding, degradation and translocation across membranes, and protein–protein interactions. This multitude of roles is not easily reconciled with the universality of the activity of HSP70s in ATP-dependent client protein-binding and release cycles. Much of the functional diversity of the HSP70s is driven by a diverse class of cofactors: J proteins. Often, multiple J proteins function with a single HSP70. Some target HSP70 activity to clients at precise locations in cells and others bind client proteins directly, thereby delivering specific clients to HSP70 and directly determining their fate. In their native cellular environment, polypeptides are participates in such diverse cellular functions. Their constantly at risk of attaining conformations that pre- functional diversity is remarkable considering that vent them from functioning properly and/or cause them within and across species, HSP70s have high sequence to aggregate into large, potentially cytotoxic complexes. identity. They share a single biochemical activity: an Molecular chaperones guide the conformation of proteins ATP-dependent client-binding and release cycle com- throughout their lifetime, preventing their aggregation bined with client protein recognition, which is typi- by protecting interactive surfaces against non-productive cally rather promiscuous. This apparent conundrum interactions. Through such inter actions, molecular chap- is resolved by the fact that HSP70s do not work alone, erones aid in the folding of nascent proteins as they are but rather as ‘HSP70 machines’, collaborating with synthesized by ribosomes, drive protein transport across and being regulated by several cofactors.
    [Show full text]
  • Heat Shock Protein 70 (HSP70) Induction: Chaperonotherapy for Neuroprotection After Brain Injury
    cells Review Heat Shock Protein 70 (HSP70) Induction: Chaperonotherapy for Neuroprotection after Brain Injury Jong Youl Kim 1, Sumit Barua 1, Mei Ying Huang 1,2, Joohyun Park 1,2, Midori A. Yenari 3,* and Jong Eun Lee 1,2,* 1 Department of Anatomy, Yonsei University College of Medicine, Seoul 03722, Korea; [email protected] (J.Y.K.); [email protected] (S.B.); [email protected] (M.Y.H.); [email protected] (J.P.) 2 BK21 Plus Project for Medical Science and Brain Research Institute, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea 3 Department of Neurology, University of California, San Francisco & the San Francisco Veterans Affairs Medical Center, Neurology (127) VAMC 4150 Clement St., San Francisco, CA 94121, USA * Correspondence: [email protected] (M.A.Y.); [email protected] (J.E.L.); Tel.: +1-415-750-2011 (M.A.Y.); +82-2-2228-1646 (ext. 1659) (J.E.L.); Fax: +1-415-750-2273 (M.A.Y.); +82-2-365-0700 (J.E.L.) Received: 17 July 2020; Accepted: 26 August 2020; Published: 2 September 2020 Abstract: The 70 kDa heat shock protein (HSP70) is a stress-inducible protein that has been shown to protect the brain from various nervous system injuries. It allows cells to withstand potentially lethal insults through its chaperone functions. Its chaperone properties can assist in protein folding and prevent protein aggregation following several of these insults. Although its neuroprotective properties have been largely attributed to its chaperone functions, HSP70 may interact directly with proteins involved in cell death and inflammatory pathways following injury.
    [Show full text]
  • Senescence Inhibits the Chaperone Response to Thermal Stress
    SUPPLEMENTAL INFORMATION Senescence inhibits the chaperone response to thermal stress Jack Llewellyn1, 2, Venkatesh Mallikarjun1, 2, 3, Ellen Appleton1, 2, Maria Osipova1, 2, Hamish TJ Gilbert1, 2, Stephen M Richardson2, Simon J Hubbard4, 5 and Joe Swift1, 2, 5 (1) Wellcome Centre for Cell-Matrix Research, Oxford Road, Manchester, M13 9PT, UK. (2) Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, M13 9PL, UK. (3) Current address: Department of Biomedical Engineering, University of Virginia, Box 800759, Health System, Charlottesville, VA, 22903, USA. (4) Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, M13 9PL, UK. (5) Correspondence to SJH ([email protected]) or JS ([email protected]). Page 1 of 11 Supplemental Information: Llewellyn et al. Chaperone stress response in senescence CONTENTS Supplemental figures S1 – S5 … … … … … … … … 3 Supplemental table S6 … … … … … … … … 10 Supplemental references … … … … … … … … 11 Page 2 of 11 Supplemental Information: Llewellyn et al. Chaperone stress response in senescence SUPPLEMENTAL FIGURES Figure S1. A EP (passage 3) LP (passage 16) 200 µm 200 µm 1.5 3 B Mass spectrometry proteomics (n = 4) C mRNA (n = 4) D 100k EP 1.0 2 p < 0.0001 p < 0.0001 LP p < 0.0001 p < 0.0001 ) 0.5 1 2 p < 0.0001 p < 0.0001 10k 0.0 0 -0.5 -1 Cell area (µm Cell area fold change vs. EP fold change vs.
    [Show full text]
  • HSP90 Interacts with the Fibronectin N-Terminal Domains and Increases Matrix Formation
    cells Article HSP90 Interacts with the Fibronectin N-terminal Domains and Increases Matrix Formation Abir Chakraborty 1 , Natasha Marie-Eraine Boel 1 and Adrienne Lesley Edkins 1,2,* 1 Biomedical Biotechnology Research Unit, Department of Biochemistry and Microbiology, Rhodes University, Grahamstown 6140, South Africa; [email protected] (A.C.); [email protected] (N.M.-E.B.) 2 Centre for Chemico- and Biomedicinal Research, Rhodes University, Grahamstown 6140, South Africa * Correspondence: [email protected] Received: 20 December 2019; Accepted: 18 January 2020; Published: 22 January 2020 Abstract: Heat shock protein 90 (HSP90) is an evolutionarily conserved chaperone protein that controls the function and stability of a wide range of cellular client proteins. Fibronectin (FN) is an extracellular client protein of HSP90, and exogenous HSP90 or inhibitors of HSP90 alter the morphology of the extracellular matrix. Here, we further characterized the HSP90 and FN interaction. FN bound to the M domain of HSP90 and interacted with both the open and closed HSP90 conformations; and the interaction was reduced in the presence of sodium molybdate. HSP90 interacted with the N-terminal regions of FN, which are known to be important for matrix assembly. The highest affinity interaction was with the 30-kDa (heparin-binding) FN fragment, which also showed the greatest colocalization in cells and accommodated both HSP90 and heparin in the complex. The strength of interaction with HSP90 was influenced by the inherent stability of the FN fragments, together with the type of motif, where HSP90 preferentially bound the type-I FN repeat over the type-II repeat. Exogenous extracellular HSP90 led to increased incorporation of both full-length and 70-kDa fragments of FN into fibrils.
    [Show full text]
  • Protein Folding: Dual Chaperone Function
    RESEARCH HIGHLIGHTS PROTEIN FOLDING Dual chaperone function Chaperones support protein folding deletion of the JJJ1 gene and the in different cellular compartments SSB1 and SSB2 genes caused cytosolic and some chaperones associate synthetic lethality, which implies and nuclear with ribosomes to help fold newly that RAC–SSB and Jji1 function in synthesized proteins. Two studies by distinct pathways. functions [of Koplin et al. and Albanèse et al. now Cells lacking both SSB and NAC chaperones] in reveal that, in addition to promoting accumulated aggregates consisting protein folding protein folding, the yeast chaperone mostly of ribosomal proteins and system RAC–SSB (ribosome-asso- pre-ribosomal RNA (rRNA) species. and ribosome ciated complex–stress 70B; in which Furthermore, double-deletion strains biogenesis RAC acts as a co-chaperone for the for RAC–SSB and NAC and for RAC functionally interchangeable SSB and Jjj1 showed a reduction in the proteins Ssb1 and Ssb2), the nascent levels of 80S ribosomes and translat- chain-associated complex (NAC) ing polysomes as well as the 60S and and the chaperone Jjj1 (which is a 40S subunits. Albanèse et al. further co-chaperone for the Hsp70 chaper- showed that the loss of Zuo1 and Jjj1 one SSA) also help with assembling led to the accumulation of immature ribosomes. 27S rRNA precursors, a hallmark of Genetic interaction studies defective 60S ribosomal subunit mat- showed that RAC, which consists uration. Microarray analysis allowed of zuotin (Zuo1) and Ssz1, and the detection of deficiencies in 27S the Zuo-like protein Jjj1, have and 35S rRNA processing in strains distinct but overlapping biological with Jji1 or RAC deletions, although functions.
    [Show full text]
  • REVIEW Heat Shock Proteins – Modulators of Apoptosis in Tumour
    Leukemia (2000) 14, 1161–1173 2000 Macmillan Publishers Ltd All rights reserved 0887-6924/00 $15.00 www.nature.com/leu REVIEW Heat shock proteins – modulators of apoptosis in tumour cells EM Creagh, D Sheehan and TG Cotter Tumour Biology Laboratory, Department of Biochemistry, University College Cork, Lee Maltings, Prospect Row, Cork, Ireland Apoptosis is a genetically programmed, physiological method ditions, when the stress level eliminates the capacity for regu- of cell destruction. A variety of genes are now recognised as lated activation of the apoptotic cascade, the cells undergo positive or negative regulators of this process. Expression of inducible heat shock proteins (hsp) is known to correlate with necrosis. At lower levels, injured cells activate their own increased resistance to apoptosis induced by a range of apoptotic programme. However, if the level of stress is low diverse cytotoxic agents and has been implicated in chemo- enough, cells attempt to survive and activate a stress response therapeutic resistance of tumours and carcinogenesis. Inten- system (Figure 1). This response involves a shut-down of all sive research on apoptosis over the past number of years has cellular protein synthesis apart from a rapid induction of heat provided significant insights into the mechanisms and molecu- shock proteins, which results in a transient state of thermotol- lar events that occur during this process. The modulatory 8 effects of hsps on apoptosis are well documented, however, erance. Once the stress element is removed, these cells func- the mechanisms of hsp-mediated protection against apoptosis tion normally and the levels of hsps drop back to basal levels remain to be fully defined, although several hypotheses have with time.
    [Show full text]
  • Genetic Disorders Involving Molecular-Chaperone Genes: a Perspective Alberto J.L
    January 2005 ⅐ Vol. 7 ⅐ No. 1 review Genetic disorders involving molecular-chaperone genes: A perspective Alberto J.L. Macario, MD1,2, Tomas M. Grippo, MD1, and Everly Conway de Macario, PhD1 Molecular chaperones are important for maintaining a functional set of proteins in all cellular compartments. Together with protein degradation machineries (e.g., the ubiquitin-proteasome system), chaperones form the core of the cellular protein-quality control mechanism. Chaperones are proteins, and as such, they can be affected by mutations. At least 15 disorders have been identified that are associated with mutations in genes encoding chaperones, or molecules with features suggesting that they function as chaperones. These chaperonopathies and a few other candidates are presented in this article. In most cases, the mechanisms by which the defective genes contribute to the observed phenotypes are still uncharacterized. However, the reported observations definitely point to the possibility that abnormal chaperones participate in pathogenesis. The available data open novel perspectives and should encourage searches for new genetic chaperonopathies, as well as further analyses of the disorders discussed in this article, including detection of new cases. Genet Med 2005:7(1):3–12. Key Words: genetic chaperonopathies, defective chaperones, structural chaperonopathies, neuromuscular diseases, eye diseases. Protein biogenesis is one of the most crucial physiological and quality of the information currently available justify a se- processes, ensuring the maintenance of a complete set of pro- rious consideration of the possibility that defective chaperones teins, correctly folded, in every cellular compartment. The contribute to pathogenesis and may even be the primary etiol- pathogenetic potential of failure in the mechanisms that assist ogy in many disorders.
    [Show full text]
  • A Chaperone Network Controls the Heat Shock Response in E. Coli
    Downloaded from genesdev.cshlp.org on September 24, 2021 - Published by Cold Spring Harbor Laboratory Press A chaperone network controls the heat shock response in E. coli Eric Guisbert,1 Christophe Herman,2,4,5 Chi Zen Lu,2 and Carol A. Gross2,3,6 Departments of 1Biochemistry and Biophysics, 2Microbiology and Immunology, and 3Stomatology, University of California, San Francisco, San Francisco, California 94143, USA; 4Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA The heat shock response controls levels of chaperones and proteases to ensure a proper cellular environment for protein folding. In Escherichia coli, this response is mediated by the bacterial-specific transcription factor, ␴32. The DnaK chaperone machine regulates both the amount and activity of ␴32, thereby coupling ␴32 function to the cellular protein folding state. In this manuscript, we analyze the ability of other major chaperones in E. coli to regulate ␴32, and we demonstrate that the GroEL/S chaperonin is an additional regulator of ␴32. We show that increasing the level of GroEL/S leads to a decrease in ␴32 activity in vivo and this effect can be eliminated by co-overexpression of a GroEL/S-specific substrate. We also show that depletion of GroEL/S in vivo leads to up-regulation of ␴32 by increasing the level of ␴32. In addition, we show that changing the levels of GroEL/S during stress conditions leads to measurable changes in the heat shock response. Using purified proteins, we show that that GroEL binds to ␴32 and decreases ␴32-dependent transcription in vitro, suggesting that this regulation is direct.
    [Show full text]
  • Targeting the Hsp90-Cdc37-Client Protein Interaction to Disrupt Hsp90 Chaperone Machinery Ting Li1, Hu-Lin Jiang2, Yun-Guang Tong3,4 and Jin-Jian Lu1*
    Li et al. Journal of Hematology & Oncology (2018) 11:59 https://doi.org/10.1186/s13045-018-0602-8 REVIEW Open Access Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery Ting Li1, Hu-Lin Jiang2, Yun-Guang Tong3,4 and Jin-Jian Lu1* Abstract Heat shock protein 90 (Hsp90) is a critical molecular chaperone protein that regulates the folding, maturation, and stability of a wide variety of proteins. In recent years, the development of Hsp90-directed inhibitors has grown rapidly, and many of these inhibitors have entered clinical trials. In parallel, the functional dissection of the Hsp90 chaperone machinery has highlighted the activity disruption of Hsp90 co-chaperone as a potential target. With the roles of Hsp90 co-chaperones being elucidated, cell division cycle 37 (Cdc37), a ubiquitous co-chaperone of Hsp90 that directs the selective client proteins into the Hsp90 chaperone cycle, shows great promise. Moreover, the Hsp90-Cdc37-client interaction contributes to the regulation of cellular response and cellular growth and is more essential to tumor tissues than normal tissues. Herein, we discuss the current understanding of the clients of Hsp90-Cdc37, the interaction of Hsp90-Cdc37-client protein, and the therapeutic possibilities of targeting Hsp90-Cdc37-client protein interaction as a strategy to inhibit Hsp90 chaperone machinery to present new insights on alternative ways of inhibiting Hsp90 chaperone machinery. Keywords: Hsp90 chaperone machinery, Cdc37, Kinase client, Protein interaction Background chloroplast HSP90C, mitochondrial TNFR-associated protein, Heat shock protein 90 (Hsp90) is a critically conserved and bacterial high-temperature protein G [2, 8]. In this protein and one of the major molecular chaperones within review,weusethetermHsp90torefertotheseHsp90 eukaryotic cells [1].
    [Show full text]
  • Conserved and Unique Roles of Chaperone-Dependent E3 Ubiquitin Ligase CHIP in Plants
    fpls-12-699756 July 3, 2021 Time: 17:33 # 1 REVIEW published: 09 July 2021 doi: 10.3389/fpls.2021.699756 Conserved and Unique Roles of Chaperone-Dependent E3 Ubiquitin Ligase CHIP in Plants Yan Zhang, Gengshou Xia and Qianggen Zhu* Department of Landscape and Horticulture, Ecology College, Lishui University, Lishui, China Protein quality control (PQC) is essential for maintaining cellular homeostasis by reducing protein misfolding and aggregation. Major PQC mechanisms include protein refolding assisted by molecular chaperones and the degradation of misfolded and aggregated proteins using the proteasome and autophagy. A C-terminus of heat shock protein (Hsp) 70-interacting protein [carboxy-terminal Hsp70-interacting protein (CHIP)] is a chaperone-dependent and U-box-containing E3 ligase. CHIP is a key molecule in PQC by recognizing misfolded proteins through its interacting chaperones and targeting their degradation. CHIP also ubiquitinates native proteins and plays a regulatory role in other Edited by: cellular processes, including signaling, development, DNA repair, immunity, and aging in Shaojun Dai, metazoans. As a highly conserved ubiquitin ligase, plant CHIP plays an important role in Shanghai Normal University, China response to a broad spectrum of biotic and abiotic stresses. CHIP protects chloroplasts Reviewed by: Deepak Chhangani, by coordinating chloroplast PQC both outside and inside the important photosynthetic University of Florida, United States organelle of plant cells. CHIP also modulates the activity of protein phosphatase 2A Ana Paulina Barba De La Rosa, Instituto Potosino de Investigación (PP2A), a crucial component in a network of plant signaling, including abscisic acid Científica y Tecnológica (IPICYT), (ABA) signaling. In this review, we discuss the structure, cofactors, activities, and Mexico biological function of CHIP with an emphasis on both its conserved and unique roles *Correspondence: in PQC, stress responses, and signaling in plants.
    [Show full text]
  • Hsp70–Hsp110 Chaperones Deliver Ubiquitin-Dependent
    © 2018. Published by The Company of Biologists Ltd | Journal of Cell Science (2018) 131, jcs210948. doi:10.1242/jcs.210948 RESEARCH ARTICLE Hsp70–Hsp110 chaperones deliver ubiquitin-dependent and -independent substrates to the 26S proteasome for proteolysis in yeast Ganapathi Kandasamy and Claes Andréasson* ABSTRACT proteasome by shuttling factors that associate with both the During protein quality control, proteotoxic misfolded proteins are ubiquitin chain and the 19S regulatory particle of the proteasome recognized by molecular chaperones, ubiquitylated by dedicated (Elsasser et al., 2004; Husnjak et al., 2008; Su and Lau, 2009). quality control ligases and delivered to the 26S proteasome for Delivered proteins are unfolded, deubiquitylated and translocated degradation. Proteins belonging to the Hsp70 chaperone and Hsp110 into the 20S proteolytic chamber of the proteasome for degradation. (the Hsp70 nucleotide exchange factor) families function in the Ubiquitin tagging is dispensable for the proteasomal degradation degradation of misfolded proteins by the ubiquitin-proteasome of a subset of cellular proteins. In such ubiquitin-independent system via poorly understood mechanisms. Here, we report that the degradation, unstructured tails that interact directly with the Saccharomyces cerevisiae Hsp110 proteins (Sse1 and Sse2) function proteasome function as degrons (Ben-Nissan and Sharon, 2014; in the degradation of Hsp70-associated ubiquitin conjugates at the Takeuchi et al., 2007; Yu et al., 2016a,b). Classical examples of post-ubiquitylation step and are also required for ubiquitin-independent proteins that undergo such ubiquitin-independent degradation in Saccharomyces cerevisiae proteasomal degradation. Hsp110 associates with the 19S regulatory include ornithine decarboxylase (ODC), particle of the 26S proteasome and interacts with Hsp70 to facilitate the Rpn4 and Pih1 (Gödderz et al., 2011; Paci et al., 2016; Xie and delivery of Hsp70 substrates for proteasomal degradation.
    [Show full text]